Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-20 5:18 pm Sale | 13D | CERO THERAPEUTICS HOLDINGS INC. CERO | PHOENIX BIOTECH SPONSOR LLC | 1,015,000 6.800% | -4,281,246 (-80.84%) | View |
| 2023-01-31 6:40 pm Unchanged | 13D | CERO THERAPEUTICS HOLDINGS INC. CERO | PHOENIX BIOTECH SPONSOR LLC | 5,296,246 78.200% | 0 (Unchanged) | View |
| 2022-02-08 4:00 pm Purchase | 13G | CERO THERAPEUTICS HOLDINGS INC. CERO | PHOENIX BIOTECH SPONSOR LLC | 5,296,246 23.000% | 5,296,246 (New Position) | View |